{"pmid":32473074,"title":"Coronavirus confinement: a chance to learn on oral cancer. The Spanish experience.","text":["Coronavirus confinement: a chance to learn on oral cancer. The Spanish experience.","Since January 11(th) , when the first 40 cases of infection by SARS-Cov-2 (COVID-19 disease) were communicated from Wuhan, in the Chinese province of Hubei, about 4.5 million confirmed cases have been reported worldwide. During this three-month period, 80,000 new cases and 11,000 deaths were registered daily. Spain holds the sad privilege of leading the European raking of confirmed cases (>228,000) and deaths (>27,000) with no consensus on the actual figures.","Oral Dis","Varela-Centelles, Pablo","Lopez-Jornet, Pia","Gonzalez-Mourelle, Alicia","Seoane, Juan","32473074"],"abstract":["Since January 11(th) , when the first 40 cases of infection by SARS-Cov-2 (COVID-19 disease) were communicated from Wuhan, in the Chinese province of Hubei, about 4.5 million confirmed cases have been reported worldwide. During this three-month period, 80,000 new cases and 11,000 deaths were registered daily. Spain holds the sad privilege of leading the European raking of confirmed cases (>228,000) and deaths (>27,000) with no consensus on the actual figures."],"journal":"Oral Dis","authors":["Varela-Centelles, Pablo","Lopez-Jornet, Pia","Gonzalez-Mourelle, Alicia","Seoane, Juan"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473074","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/odi.13445","keywords":["confinement","continuing education","coronavirus","oral cancer"],"locations":["Wuhan","Chinese","Hubei","Spain","Spanish"],"countries":["Spain","China"],"countries_codes":["ESP|Spain","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668255193392742401,"score":9.490897,"similar":[{"pmid":32365287,"title":"Emergency department COVID management policies: one institution's experience and lessons learned.","text":["Emergency department COVID management policies: one institution's experience and lessons learned.","Coronavirus disease (COVID-19), caused by the SARS-CoV-2 virus, originated in Wuhan, Hubei Province, China in late 2019 and grew rapidly into a pandemic. As of the writing of this monograph, there are over 2 million confirmed cases worldwide and 147,000 deaths. New York City, with over 120,000 COVID-19-positive patients and over 11,000 deaths, has become the infection epicenter in the United States. The Mount Sinai Health System, with 8 hospitals spread across New York City and Long Island, has been on the forefront of the pandemic. This compendium summarizes the lessons learned through interdisciplinary collaborations to meet the varied challenges created by the explosive appearance of the infection in our community, and will be updated continuously as new research and best practices emerge. It is our hope is that the collaborations and lessons learned that went into creating these guidelines and protocols can serve as a useful template for other systems to adapt to their fight against COVID-19.","Emerg Med Pract","Leibner, Evan S","Stokes, Sonya","Ahmad, Danish","Legome, Eric","32365287"],"abstract":["Coronavirus disease (COVID-19), caused by the SARS-CoV-2 virus, originated in Wuhan, Hubei Province, China in late 2019 and grew rapidly into a pandemic. As of the writing of this monograph, there are over 2 million confirmed cases worldwide and 147,000 deaths. New York City, with over 120,000 COVID-19-positive patients and over 11,000 deaths, has become the infection epicenter in the United States. The Mount Sinai Health System, with 8 hospitals spread across New York City and Long Island, has been on the forefront of the pandemic. This compendium summarizes the lessons learned through interdisciplinary collaborations to meet the varied challenges created by the explosive appearance of the infection in our community, and will be updated continuously as new research and best practices emerge. It is our hope is that the collaborations and lessons learned that went into creating these guidelines and protocols can serve as a useful template for other systems to adapt to their fight against COVID-19."],"journal":"Emerg Med Pract","authors":["Leibner, Evan S","Stokes, Sonya","Ahmad, Danish","Legome, Eric"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365287","source":"PubMed","week":"202019|May 04 - May 10","locations":["Wuhan","Hubei","China","New York","United States","New York"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495976996865,"score":139.40463},{"pmid":32426855,"title":"Active implications for dermatologists in \"SARS-CoV-2 era\": Personal experience and review of literature.","text":["Active implications for dermatologists in \"SARS-CoV-2 era\": Personal experience and review of literature.","On December 31, 2019, from the Chinese city of Wuhan, Hubei, comes the first case of \"atypical ARDS/ interstitial pneumonia\". On February 11, 2020 the WHO officially announced the name of the emergent disease associated with new coronavirus identified as SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus -2): COVID-19 (Coronavirus Disease 2019) (1). On February 13, 72000 cases have been officially recorded in China, among which 15000 were registered in Hubei province only, with 242 deaths in a single day. After that, Chinese republic has ordered drastic containment measures for fighting SARS-CoV-2 virus spreading (1).","J Eur Acad Dermatol Venereol","Campanati, A","Brisigotti, V","Diotallevi, F","D'Agostino, G M","Paolinelli, M","Radi, G","Rizzetto, G","Sapigni, C","Tagliati, C","Offidani, A","32426855"],"abstract":["On December 31, 2019, from the Chinese city of Wuhan, Hubei, comes the first case of \"atypical ARDS/ interstitial pneumonia\". On February 11, 2020 the WHO officially announced the name of the emergent disease associated with new coronavirus identified as SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus -2): COVID-19 (Coronavirus Disease 2019) (1). On February 13, 72000 cases have been officially recorded in China, among which 15000 were registered in Hubei province only, with 242 deaths in a single day. After that, Chinese republic has ordered drastic containment measures for fighting SARS-CoV-2 virus spreading (1)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Campanati, A","Brisigotti, V","Diotallevi, F","D'Agostino, G M","Paolinelli, M","Radi, G","Rizzetto, G","Sapigni, C","Tagliati, C","Offidani, A"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426855","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jdv.16646","keywords":["covid-19","sars-cov-2","coronavirus","dermatology","ncov","skin diseases"],"locations":["Chinese","Wuhan","Hubei","China","Hubei","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667352728759697409,"score":117.97031},{"pmid":32499176,"title":"Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication.","text":["Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication.","COVID-19 has spread worldwide, with more than 2.5 million cases and over 80,000 deaths reported by the end of April 2020. In addition to pulmonary symptoms, gastrointestinal symptoms have been increasingly recognized as part of the disease spectrum. COVID-19-associated coagulopathy has recently emerged as a major component of the disease, leading to high morbidity and mortality. Ischemic colitis has been reported to be associated with a hypercoagulable state. To our knowledge, there have not been any case reports of COVID-19 associated with ischemic colitis. Herein, we present the first case of a probable association of COVID-19 with ischemic colitis in a patient with a hypercoagulable state.","Am J Emerg Med","Chan, Kok Hoe","Lim, Su Lin","Damati, Ahmad","Maruboyina, Siva Prasad","Bondili, Leena","Abu Hanoud, Amany","Slim, Jihad","32499176"],"abstract":["COVID-19 has spread worldwide, with more than 2.5 million cases and over 80,000 deaths reported by the end of April 2020. In addition to pulmonary symptoms, gastrointestinal symptoms have been increasingly recognized as part of the disease spectrum. COVID-19-associated coagulopathy has recently emerged as a major component of the disease, leading to high morbidity and mortality. Ischemic colitis has been reported to be associated with a hypercoagulable state. To our knowledge, there have not been any case reports of COVID-19 associated with ischemic colitis. Herein, we present the first case of a probable association of COVID-19 with ischemic colitis in a patient with a hypercoagulable state."],"journal":"Am J Emerg Med","authors":["Chan, Kok Hoe","Lim, Su Lin","Damati, Ahmad","Maruboyina, Siva Prasad","Bondili, Leena","Abu Hanoud, Amany","Slim, Jihad"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499176","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ajem.2020.05.072","keywords":["covid-19","coronavirus","hypercoagulability","ischemic colitis","sars-cov-2"],"locations":["Ischemic"],"topics":["Case Report"],"weight":1,"_version_":1668804508707192832,"score":103.338455},{"pmid":32369674,"title":"Oral vesiculobullous lesions associated with SARS-CoV-2 infection.","text":["Oral vesiculobullous lesions associated with SARS-CoV-2 infection.","The coronavirus pandemic that began in China at the end of last year, claimed its first confirmed death in Spain at the end of January 2020, where to date, 200,000 infections and 20,852 deaths have been recorded. In addition to the manifestations of SARS-CoV-2 infection described in the literature (fever, dry cough, diarrhea, and respiratory involvement) recently, skin exanthematic lesions have been described. We present three cases (two suspected and one confirmed) of patients presenting ulcers in the oral cavity. Oral manifestations developed during the lock-down period between the last week of March and the first week of April 2020, and consisted of pain, desquamative gingivitis, ulcers and blisters. To the best of our knowledge, this is the first case report describing of a COVID-19 patient with oral manifestations. Intraoral examinations should be carried out in patients affected by SARS-CoV-2, always when having the recommended protection measures available to a better understanding of the disease.","Oral Dis","Martin Carreras-Presas, Carmen","Amaro Sanchez, Juan","Lopez-Sanchez, Antonio Francisco","Jane-Salas, Enric","Somacarrera Perez, Maria Luisa","32369674"],"abstract":["The coronavirus pandemic that began in China at the end of last year, claimed its first confirmed death in Spain at the end of January 2020, where to date, 200,000 infections and 20,852 deaths have been recorded. In addition to the manifestations of SARS-CoV-2 infection described in the literature (fever, dry cough, diarrhea, and respiratory involvement) recently, skin exanthematic lesions have been described. We present three cases (two suspected and one confirmed) of patients presenting ulcers in the oral cavity. Oral manifestations developed during the lock-down period between the last week of March and the first week of April 2020, and consisted of pain, desquamative gingivitis, ulcers and blisters. To the best of our knowledge, this is the first case report describing of a COVID-19 patient with oral manifestations. Intraoral examinations should be carried out in patients affected by SARS-CoV-2, always when having the recommended protection measures available to a better understanding of the disease."],"journal":"Oral Dis","authors":["Martin Carreras-Presas, Carmen","Amaro Sanchez, Juan","Lopez-Sanchez, Antonio Francisco","Jane-Salas, Enric","Somacarrera Perez, Maria Luisa"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369674","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/odi.13382","keywords":["covid-19","mucocutaneous viral lesions","oral mucosal lesions"],"locations":["China","Spain"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Case Report"],"weight":1,"_version_":1666138496163643394,"score":101.35916},{"pmid":32268195,"pmcid":"PMC7130124","title":"Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: A population-level retrospective study.","text":["Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: A population-level retrospective study.","BACKGROUND: A novel coronavirus emerged in China in December 2019, and human-to-human transmission was previously identified. This study aimed to compare the epidemiological characteristics in Jiangsu Province and assess whether so-called wartime control measures changed the trend of coronavirus disease 2019 (COVID-19) in the province. METHODS: Epidemiological data were obtained from the websites of China's Bureau of Health and the People's Government of Jiangsu Province and informal online sources from January 22 to February 20, 2020. RESULTS: The cumulative number of patients in Jiangsu Province (over 79 million people) was 613. The number of daily confirmed new cases reached the inflection point on January 31 with the maximum of 39 cases. The temporal number of patients peaked from January 29 to February 9. The proportion of confirmed cases who were residents or travelers to Hubei Province was 100.0%-58.8% before January 31 and then gradually declined. The proportion of close contacts increased gradually from January 27 to February 17. The geographical distribution of COVID-2019 cases showed that all 13 cites reported confirmed new cases after only five days of the first confirmed new case in Suzhou. The cases were concentrated in Nanjing, Suzhou, and Xuzhou with a high population density (over eight million people). The epidemiological features of COVID-2019 cases in Wuxi, Jiangsu showed that seven confirmed cases were tourists from others areas beyond Hubei Province. The longest incubation period of COVID-2019 was 19 days based on the onset of laboratory-confirmed cases. CONCLUSION: The number of daily confirmed new cases in Jiangsu Province peaked around January 31 and then declined. This result emphasized that wartime control measures, such as putting cities on lockdown to limit population mobility in Jiangsu Province, resulted in dramatic reductions in COVID-19 cases.","Travel Med Infect Dis","Wang, Ke-Wei","Gao, Jie","Wang, Hua","Wu, Xiao-Long","Yuan, Qin-Fang","Guo, Fei-Yu","Zhang, Zhi-Jie","Cheng, Yang","32268195"],"abstract":["BACKGROUND: A novel coronavirus emerged in China in December 2019, and human-to-human transmission was previously identified. This study aimed to compare the epidemiological characteristics in Jiangsu Province and assess whether so-called wartime control measures changed the trend of coronavirus disease 2019 (COVID-19) in the province. METHODS: Epidemiological data were obtained from the websites of China's Bureau of Health and the People's Government of Jiangsu Province and informal online sources from January 22 to February 20, 2020. RESULTS: The cumulative number of patients in Jiangsu Province (over 79 million people) was 613. The number of daily confirmed new cases reached the inflection point on January 31 with the maximum of 39 cases. The temporal number of patients peaked from January 29 to February 9. The proportion of confirmed cases who were residents or travelers to Hubei Province was 100.0%-58.8% before January 31 and then gradually declined. The proportion of close contacts increased gradually from January 27 to February 17. The geographical distribution of COVID-2019 cases showed that all 13 cites reported confirmed new cases after only five days of the first confirmed new case in Suzhou. The cases were concentrated in Nanjing, Suzhou, and Xuzhou with a high population density (over eight million people). The epidemiological features of COVID-2019 cases in Wuxi, Jiangsu showed that seven confirmed cases were tourists from others areas beyond Hubei Province. The longest incubation period of COVID-2019 was 19 days based on the onset of laboratory-confirmed cases. CONCLUSION: The number of daily confirmed new cases in Jiangsu Province peaked around January 31 and then declined. This result emphasized that wartime control measures, such as putting cities on lockdown to limit population mobility in Jiangsu Province, resulted in dramatic reductions in COVID-19 cases."],"journal":"Travel Med Infect Dis","authors":["Wang, Ke-Wei","Gao, Jie","Wang, Hua","Wu, Xiao-Long","Yuan, Qin-Fang","Guo, Fei-Yu","Zhang, Zhi-Jie","Cheng, Yang"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32268195","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.tmaid.2020.101654","keywords":["covid-19","close contacts","jiangsu","wartime control measures"],"locations":["China","Jiangsu","China","Jiangsu","Hubei","Suzhou","Nanjing","Suzhou","Xuzhou","Wuxi","Jiangsu","Hubei","Jiangsu","Jiangsu","Jiangsu","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491903279107,"score":99.014946}]}